These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33520799)

  • 21. The association between anti-diabetic agents and osteoporosis, sarcopenia, and osteosarcopenia among Iranian older adults; Bushehr Elderly Health (BEH) program.
    Sohi YH; Golestani A; Panahi G; Tabatabaei-Malazy O; Khalagi K; Fahimfar N; Ostovar A; Sanjari M; Larijani B; Nabipour I
    Daru; 2024 Jun; 32(1):145-159. PubMed ID: 38133840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between Sarcopenia and Frailty in the Toledo Study of Healthy Aging: A Population Based Cross-Sectional Study.
    Davies B; García F; Ara I; Artalejo FR; Rodriguez-Mañas L; Walter S
    J Am Med Dir Assoc; 2018 Apr; 19(4):282-286. PubMed ID: 29079029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients.
    Reiss J; Iglseder B; Alzner R; Mayr-Pirker B; Pirich C; Kässmann H; Kreutzer M; Dovjak P; Reiter R
    Age Ageing; 2019 Sep; 48(5):719-724. PubMed ID: 31112221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS).
    Patel HP; Syddall HE; Jameson K; Robinson S; Denison H; Roberts HC; Edwards M; Dennison E; Cooper C; Aihie Sayer A
    Age Ageing; 2013 May; 42(3):378-84. PubMed ID: 23384705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic differences and agreement between the original and revised European Working Group (EWGSOP) consensus definition for sarcopenia in community-dwelling older adults with type 2 diabetes mellitus.
    Villani A; McClure R; Barrett M; Scott D
    Arch Gerontol Geriatr; 2020; 89():104081. PubMed ID: 32485520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review.
    Fernandes LV; Paiva AEG; Silva ACB; de Castro IC; Santiago AF; de Oliveira EP; Porto LCJ
    Aging Clin Exp Res; 2022 Mar; 34(3):505-514. PubMed ID: 34398438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the European Working Group on Sarcopenia in Older People algorithm in screening older adults for muscle mass assessment.
    Lourenço RA; Pérez-Zepeda M; Gutiérrez-Robledo L; García-García FJ; Rodríguez Mañas L
    Age Ageing; 2015 Mar; 44(2):334-8. PubMed ID: 25539836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People.
    Bachettini NP; Bielemann RM; Barbosa-Silva TG; Menezes AMB; Tomasi E; Gonzalez MC
    Eur J Clin Nutr; 2020 Apr; 74(4):573-580. PubMed ID: 31586126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between nutrient intakes and dietary patterns with different sarcopenia definitions in older Australian men: the concord health and ageing in men project.
    Das A; Cumming RG; Naganathan V; Blyth F; Le Couteur DG; Handelsman DJ; Waite LM; Ribeiro RV; Simpson SJ; Hirani V
    Public Health Nutr; 2021 Oct; 24(14):4490-4505. PubMed ID: 33023717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort - a comparison to the EWGSOP2 cut-off points.
    Huemer MT; Kluttig A; Fischer B; Ahrens W; Castell S; Ebert N; Gastell S; Jöckel KH; Kaaks R; Karch A; Keil T; Kemmling Y; Krist L; Leitzmann M; Lieb W; Meinke-Franze C; Michels KB; Mikolajczyk R; Moreno Velásquez I; Pischon T; Schipf S; Schmidt B; Schöttker B; Schulze MB; Stocker H; Teismann H; Wirkner K; Drey M; Peters A; Thorand B
    Age Ageing; 2023 Jan; 52(1):. PubMed ID: 36702514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Tools for Sarcopenia: Can We Get Less Expensive and Accurate Methods?
    Setiati S
    Acta Med Indones; 2019 Apr; 51(2):93-94. PubMed ID: 31383822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prevalence of Sarcopenia in Chinese Elderly Nursing Home Residents: A Comparison of 4 Diagnostic Criteria.
    Zeng Y; Hu X; Xie L; Han Z; Zuo Y; Yang M
    J Am Med Dir Assoc; 2018 Aug; 19(8):690-695. PubMed ID: 29891183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenia Definitions and Their Associations With Mortality in Older Australian Women.
    Sim M; Prince RL; Scott D; Daly RM; Duque G; Inderjeeth CA; Zhu K; Woodman RJ; Hodgson JM; Lewis JR
    J Am Med Dir Assoc; 2019 Jan; 20(1):76-82.e2. PubMed ID: 30527277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People: The GLISTEN Study.
    Bianchi L; Abete P; Bellelli G; Bo M; Cherubini A; Corica F; Di Bari M; Maggio M; Manca GM; Rizzo MR; Rossi AP; Landi F; Volpato S;
    J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1575-1581. PubMed ID: 28329345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and physical components linked to sarcopenia: The SarcoPhAge study.
    Beaudart C; Reginster JY; Petermans J; Gillain S; Quabron A; Locquet M; Slomian J; Buckinx F; Bruyère O
    Exp Gerontol; 2015 Sep; 69():103-10. PubMed ID: 25979160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different assessment tools to detect sarcopenia in patients with Parkinson's disease.
    Valent D; Peball M; Krismer F; Lanbach A; Zemann S; Horlings C; Poewe W; Seppi K
    Front Neurol; 2022; 13():1014102. PubMed ID: 36518192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Sarcopenia Employing Population-Specific Cut-Points: Cross-Sectional Data from the Geelong Osteoporosis Study, Australia.
    Sui SX; Holloway-Kew KL; Hyde NK; Williams LJ; Tembo MC; Leach S; Pasco JA
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study.
    Legrand D; Vaes B; Matheï C; Swine C; Degryse JM
    Age Ageing; 2013 Nov; 42(6):727-34. PubMed ID: 24014657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cut-off points to screening for sarcopenia in community-dwelling older people residents in Brazil.
    Fernandes SGG; Lima de Andrade LE; Dos Santos Aguiar Gonçalves RS; Aires da Câmara SM; Guerra RO; Cavalcanti Maciel AC
    PeerJ; 2021; 9():e12038. PubMed ID: 34527442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program.
    Fathi M; Heshmat R; Ebrahimi M; Salimzadeh A; Ostovar A; Fathi A; Razi F; Nabipour I; Moghaddassi M; Shafiee G
    BMC Geriatr; 2021 Nov; 21(1):654. PubMed ID: 34798818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.